热门资讯> 正文

催化剂制药公司2026年第一季度盈利预览

2026-05-11 05:35

催化剂制药(CPRX) 0

Catalyst Pharmaceuticals, Inc. (CPRX) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close.
The consensus EPS Estimate is $0.64 (-5.9% Y/Y) and the consensus Revenue Estimate is $148.18M (+5.1% Y/Y).
Over the last 2 years, CPRX has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 3 upward revisions and 2 downward.

More on Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals: Favorable Trial Outcome Could Be A Meaningful Overhang
Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript
Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1B
Catalyst Pharmaceuticals jumps on report of interest from Angelini Pharma

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。